These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 9065962

  • 1. Kava-kava extract WS 1490 versus placebo in anxiety disorders--a randomized placebo-controlled 25-week outpatient trial.
    Volz HP, Kieser M.
    Pharmacopsychiatry; 1997 Jan; 30(1):1-5. PubMed ID: 9065962
    [Abstract] [Full Text] [Related]

  • 2. [Effect of a special kava extract in patients with anxiety-, tension-, and excitation states of non-psychotic genesis. Double blind study with placebos over 4 weeks].
    Kinzler E, Krömer J, Lehmann E.
    Arzneimittelforschung; 1991 Jun; 41(6):584-8. PubMed ID: 1930344
    [Abstract] [Full Text] [Related]

  • 3. Treatment of anxiety, tension and restlessness states with Kava special extract WS 1490 in general practice: a randomized placebo-controlled double-blind multicenter trial.
    Gastpar M, Klimm HD.
    Phytomedicine; 2003 Nov; 10(8):631-9. PubMed ID: 14692723
    [Abstract] [Full Text] [Related]

  • 4. Kava treatment in patients with anxiety.
    Geier FP, Konstantinowicz T.
    Phytother Res; 2004 Apr; 18(4):297-300. PubMed ID: 15162364
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of kava-kava in the treatment of non-psychotic anxiety, following pretreatment with benzodiazepines.
    Malsch U, Kieser M.
    Psychopharmacology (Berl); 2001 Sep; 157(3):277-83. PubMed ID: 11605083
    [Abstract] [Full Text] [Related]

  • 6. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study.
    Sarris J, Stough C, Bousman CA, Wahid ZT, Murray G, Teschke R, Savage KM, Dowell A, Ng C, Schweitzer I.
    J Clin Psychopharmacol; 2013 Oct; 33(5):643-8. PubMed ID: 23635869
    [Abstract] [Full Text] [Related]

  • 7. St John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trial.
    Volz HP, Murck H, Kasper S, Möller HJ.
    Psychopharmacology (Berl); 2002 Nov; 164(3):294-300. PubMed ID: 12424553
    [Abstract] [Full Text] [Related]

  • 8. Kava-kava extract in anxiety disorders: an outpatient observational study.
    Scherer J.
    Adv Ther; 1998 Nov; 15(4):261-9. PubMed ID: 10186945
    [Abstract] [Full Text] [Related]

  • 9. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
    Cutler NR, Sramek JJ, Keppel Hesselink JM, Krol A, Roeschen J, Rickels K, Schweizer E.
    J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
    [Abstract] [Full Text] [Related]

  • 10. Meta-analysis of the efficacy of the acetonic kava-kava extract WS1490 in patients with non-psychotic anxiety disorders.
    Witte S, Loew D, Gaus W.
    Phytother Res; 2005 Mar; 19(3):183-8. PubMed ID: 15934028
    [Abstract] [Full Text] [Related]

  • 11. [Psychosomatic dysfunctions in the female climacteric. Clinical effectiveness and tolerance of Kava Extract WS 1490].
    Warnecke G.
    Fortschr Med; 1991 Feb 10; 109(4):119-22. PubMed ID: 2029982
    [Abstract] [Full Text] [Related]

  • 12. Kava for the treatment of generalised anxiety disorder (K-GAD): study protocol for a randomised controlled trial.
    Savage KM, Stough CK, Byrne GJ, Scholey A, Bousman C, Murphy J, Macdonald P, Suo C, Hughes M, Thomas S, Teschke R, Xing C, Sarris J.
    Trials; 2015 Nov 02; 16():493. PubMed ID: 26527536
    [Abstract] [Full Text] [Related]

  • 13. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H, Raassina R, Penttinen J, Ahokas A, Jokinen R, Koponen H, Lepola U, Kanerva H, Lehtonen L, Pohjalainen T, Partanen A, Mäki-Ikola O, Rouru J, Deramciclane Dose-Finding Study Group.
    Eur Neuropsychopharmacol; 2005 Dec 02; 15(6):617-23. PubMed ID: 15949921
    [Abstract] [Full Text] [Related]

  • 14. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.
    Kasper S, Volz HP, Möller HJ, Dienel A, Kieser M.
    Eur Neuropsychopharmacol; 2008 Nov 02; 18(11):803-13. PubMed ID: 18694635
    [Abstract] [Full Text] [Related]

  • 15. Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder.
    Bose A, Korotzer A, Gommoll C, Li D.
    Depress Anxiety; 2008 Nov 02; 25(10):854-61. PubMed ID: 18050245
    [Abstract] [Full Text] [Related]

  • 16. The safety and efficacy of ipsapirone vs. lorazepam in outpatients with generalized anxiety disorder (GAD): single site findings from a multicenter trial.
    Cutler NR, Sramek JJ, Wardle TS, Hesselink JM, Roeschen JK.
    Psychopharmacol Bull; 1993 Nov 02; 29(2):303-8. PubMed ID: 7904761
    [Abstract] [Full Text] [Related]

  • 17. Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study.
    Sarris J, Byrne GJ, Bousman CA, Cribb L, Savage KM, Holmes O, Murphy J, Macdonald P, Short A, Nazareth S, Jennings E, Thomas SR, Ogden E, Chamoli S, Scholey A, Stough C.
    Aust N Z J Psychiatry; 2020 Mar 02; 54(3):288-297. PubMed ID: 31813230
    [Abstract] [Full Text] [Related]

  • 18. Double-blind study of metaclazepam versus diazepam treatment of outpatients with anxiety syndrome.
    Laakmann G, Blaschke D, Hippius H, Schewe S.
    Pharmacopsychiatry; 1989 May 02; 22(3):120-5. PubMed ID: 2568645
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial.
    Rynn M, Russell J, Erickson J, Detke MJ, Ball S, Dinkel J, Rickels K, Raskin J.
    Depress Anxiety; 2008 May 02; 25(3):182-9. PubMed ID: 17311303
    [Abstract] [Full Text] [Related]

  • 20. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.
    Eur Neuropsychopharmacol; 2004 Dec 02; 14(6):457-70. PubMed ID: 15589385
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.